Los puntos clave no están disponibles para este artículo en este momento.
Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact. Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine. A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated. Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.
Building similarity graph...
Analyzing shared references across papers
Loading...
Edwin G. Tse
University of North Carolina at Chapel Hill
Marat Korsik
The University of Sydney
Matthew H. Todd
Structural Genomics Consortium
Malaria Journal
SHILAP Revista de lepidopterología
University College London
The University of Sydney
UNSW Sydney
Building similarity graph...
Analyzing shared references across papers
Loading...
Tse et al. (Fri,) studied this question.
synapsesocial.com/papers/69dff6242833447a7e25574e — DOI: https://doi.org/10.1186/s12936-019-2724-z